Capstone Therapeutics Corp. was a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. Effective April 1, 2020, the Company merged with Totalstone, LLC, a materials distribution company that distributes... Capstone Therapeutics Corp. was a biotechnology company committed to developing a pipeline of novel therapeutic peptides aimed at helping patients with under-served medical conditions. Effective April 1, 2020, the Company merged with Totalstone, LLC, a materials distribution company that distributes masonry stone products in the Midwest and Northeast United States, under the trade names of Instone and Northeast Masonry Distributors' and which going forward will be the Company's primary business activity. 더 보기
EDISON EQUITY RESEARCH: CAPSTONE THERAPEUTICS - FOCUS ON ACUTE PANCREATITIS Capstone is investigating a promising new indication for its Apo-E mimetics triglyceride lowering in acute pancreatitis...
EDISON EQUITY RESEARCH: CAPSTONE THERAPEUTICS - INITIAL PROOF-OF-CONCEPT ESTABLISHED AEM-28 has demonstrated significant reductions in both VLDL and triglycerides in the Phase I/II programme...
EDISON EQUITY RESEARCH - CAPSTONE THERAPEUTICS: FIRST HUMAN LIPID BIOMARKER TRENDS Early data in healthy volunteers have demonstrated trends in favour of AEM-28 on a number of lipid biomarkers...
TEMPE, Ariz., June 11, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), announced today the...
TEMPE, Ariz., May 16, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Wednesday, May 21, 2014 at 4:30 pm EDT. The call may...
TEMPE, Ariz., April 8, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), announced today the...
TEMPE, Ariz., March 27, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) ("the Company") and its joint venture affiliate, LipimetiX Development, LLC ("JV"), today will hold a...
TEMPE, Ariz., March 24, 2014 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS); (the "Company"), will hold a conference call and webcast on Thursday, March 27, 2014 at 4:30 pm EDT. The call...
TEMPE, Ariz. and BOSTON, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics' (OTCQB:CAPS) joint venture, LipimetiX Development, LLC, today announced the presentation of pre-clinical data...
TEMPE, Ariz., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Capstone Therapeutics (OTCQB:CAPS) (the "Company"), today will hold a conference call and webcast to provide an operating update and announced...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | -0.8 | -20 | 4 | 4 | 3.2 | 176 | 3.50426829 | CS |
26 | -0.9 | -21.9512195122 | 4.1 | 4.5 | 3.2 | 260 | 3.9069929 | CS |
52 | -2 | -38.4615384615 | 5.2 | 5.25 | 3.2 | 262 | 4.15472988 | CS |
156 | -14.05 | -81.4492753623 | 17.25 | 37.5 | 3.2 | 252 | 16.59382193 | CS |
260 | -10.9 | -77.304964539 | 14.1 | 37.5 | 3.2 | 278 | 18.74888566 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관